INTERSTITIAL LUNG DISEASES

This study tests whether the drug nerandomilast can help people with lung scarring caused by autoimmune diseases like rheumatoid arthritis or scleroderma. About 400 adults who haven't improved on standard treatment will take either nerandomilast or a placebo twice daily for at le…

This study tests a medicine called nerandomilast in people aged 40+ who have a family member with pulmonary fibrosis and early lung changes on scans. The goal is to see if the drug can slow or prevent worsening of lung damage. Participants take a tablet twice a day for about 2-3 …

This study is building a large collection of blood, tissue, and fluid samples from 7,000 people with lung cancer, other chest diseases, or lung transplants. The goal is to help researchers learn more about what causes these diseases, how to find them early, and how to treat them …

This study follows up to 4,000 people with interstitial lung disease (ILD) to understand how the condition naturally progresses. Researchers will collect medical data and blood samples from participants, as well as from a control group without ILD, to describe the disease's patte…

This study is for children and adults with interstitial lung disease, a group of conditions that scar the lungs and make breathing hard. Researchers will follow 3000 patients and their relatives for up to 10 years, collecting medical data and genetic information. The goal is to l…

This study will use advanced CT scans to look at both the lungs and heart in people with interstitial lung disease (ILD). The goal is to find early signs of heart problems, which are common but often missed until serious. Researchers hope to create better ways to predict and mana…

This study aims to better understand the physical origins of ultrasound artifacts seen in lung scans of people with interstitial lung disease or COPD. Researchers will compare ultrasound findings with CT scans in 25 participants. The goal is to improve how these ultrasound signs …